Sustained delivery of a novel natriuretic peptide for three weeks with in situ polymer precipitation delivery system
CD-NP (Cenderitide) is a chimeric natriuretic peptide that acts on both the A and B natriuretic guanylyl cylcase receptors. This differentiated mechanism of action avoids the hypotensive nature of BNP while retaining the cardiac unloading and renal enhancing actions in heart failure (HF) together wi...
Main Authors: | Lim, Soo G., Ameenuddin, Syed, Burnett Jr, John C., Venkatraman, Subbu S., Chen, Horng H. |
---|---|
Other Authors: | School of Materials Science & Engineering |
Format: | Journal Article |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/96935 http://hdl.handle.net/10220/9976 |
Similar Items
-
In-vivo evaluation of an in situ polymer precipitation delivery system for a novel natriuretic peptide
by: Venkatraman, Subbu S., et al.
Published: (2013) -
A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
by: Martin, Fernando L., et al.
Published: (2015) -
In vitro and in vivo studies of controlled release of novel peptide from in situ polymer precipitation delivery system
by: Lim, Soo Ghim
Published: (2014) -
Peptide conjugation to enhance oligonucleotide delivery
by: Wolfe, Justin Mahoney
Published: (2018) -
In vitro sustained release of novel natriuretic peptide from solvent evaporation delivery system
by: Ong, Crystal Li En
Published: (2016)